Related references
Note: Only part of the references are listed.Correlation between the expression of cancer stem cell marker BMI1 and glioma prognosis
Yu-Ting Tsai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential
Isabel R. Schlaepfer et al.
ENDOCRINOLOGY (2020)
AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis
Tzu-Chi Chen et al.
REDOX BIOLOGY (2020)
Metabolic reprogramming and cancer progression
Brandon Faubert et al.
SCIENCE (2020)
Enhanced fatty acid oxidation provides glioblastoma cells metabolic plasticity to accommodate to its dynamic nutrient microenvironment
Shiva Kant et al.
CELL DEATH & DISEASE (2020)
Mitochondrial-associated impairments of temozolomide on neural stem/progenitor cells and hippocampal neurons
Naomi Lomeli et al.
MITOCHONDRION (2020)
Betulinic Acid-Mediated Tuning of PERK/CHOP Signaling by Sp1 Inhibition as a Novel Therapeutic Strategy for Glioblastoma
Wei-Lun Lo et al.
CANCERS (2020)
Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma
Wen-Bin Yang et al.
NEURO-ONCOLOGY (2020)
KRAS Controls Pancreatic Cancer Cell Lipid Metabolism and Invasive Potential through the Lipase HSL
Cody N. Rozeveld et al.
CANCER RESEARCH (2020)
Dehydroepiandrosterone Induces Temozolomide Resistance Through Modulating Phosphorylation and Acetylation of Sp1 in Glioblastoma
Wen-Bin Yang et al.
MOLECULAR NEUROBIOLOGY (2019)
Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth
Jiange Qiu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Adipocyte and lipid metabolism in cancer drug resistance
Yihai Cao
JOURNAL OF CLINICAL INVESTIGATION (2019)
Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation
Antoinette van Weverwijk et al.
NATURE COMMUNICATIONS (2019)
CYP17A1 Maintains the Survival of Glioblastomas by Regulating SAR1-Mediated Endoplasmic Reticulum Health and Redox Homeostasis
Hong-Yi Lin et al.
CANCERS (2019)
ANGPTL4 Induces TMZ Resistance of Glioblastoma by Promoting Cancer Stemness Enrichment via the EGFR/AKT/4E-BP1 Cascade
Yu-Ting Tsai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Kruppel-like factor 4 (KLF4) induces mitochondrial fusion and increases spare respiratory capacity of human glioblastoma cells
Shuyan Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Updates in prognostic markers for gliomas
Elisa Aquilanti et al.
NEURO-ONCOLOGY (2018)
Prostaglandin E2 increases migration and proliferation of human glioblastoma cells by activating transient receptor potential melastatin 7 channels
Yafei Tian et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision
Takashi Komori
NEUROLOGIA MEDICO-CHIRURGICA (2017)
The mitochondrial dynamics in cancer and immune-surveillance
Luca Simula et al.
SEMINARS IN CANCER BIOLOGY (2017)
Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma
J-Y Chuang et al.
ONCOGENESIS (2017)
Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase
Kwang-Yu Chang et al.
REDOX BIOLOGY (2017)
The Close interconnection between Mitochondrial Dynamics and Mitophagy in Cancer
Matteo Bordi et al.
FRONTIERS IN ONCOLOGY (2017)
Stress stimuli induce cancer-sternness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma
Kwang-Yu Chang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins
Sarah E. Calvo et al.
NUCLEIC ACIDS RESEARCH (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma
Peter J. Cook et al.
NEURO-ONCOLOGY (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
G. O'Callaghan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Sp1 and the 'hallmarks of cancer'
Kate Beishline et al.
FEBS JOURNAL (2015)
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma
Marta Penas-Prado et al.
NEURO-ONCOLOGY (2015)
Lipogenesis in cancer progression (Review)
Catherine Mounier et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway
Shukai Xia et al.
ONCOLOGY REPORTS (2014)
Transport Rankings of Non-Steroidal Antiinflammatory Drugs across Blood-Brain Barrier In Vitro Models
Iveta Novakova et al.
PLOS ONE (2014)
Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer
Grace O'Callaghan et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance
Jennifer Pasquier et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics
Manti Guha et al.
MITOCHONDRION (2013)
Regulation of Immune Responses by Prostaglandin E-2
Pawel Kalinski
JOURNAL OF IMMUNOLOGY (2012)
Prostaglandin E2 promotes intestinal tumor growth via DNA methylation
Dianren Xia et al.
NATURE MEDICINE (2012)
ANGPTL4 Induction by Prostaglandin E2 under Hypoxic Conditions Promotes Colorectal Cancer Progression
Sun-Hee Kim et al.
CANCER RESEARCH (2011)
Acquisition of Temozolomide Chemoresistance in Gliomas Leads to Remodeling of Mitochondrial Electron Transport Chain
Claudia R. Oliva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Prostaglandin E2/EP1 Signaling Pathway Enhances Intercellular Adhesion Molecule 1 (ICAM-1) Expression and Cell Motility in Oral Cancer Cells
Shun-Fa Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Fas Signal Promotes Lung Cancer Growth by Recruiting Myeloid-Derived Suppressor Cells via Cancer Cell-Derived PGE2
Yongliang Zhang et al.
JOURNAL OF IMMUNOLOGY (2009)
Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy
Khong Bee Kang et al.
MOLECULAR CANCER (2009)
Serum GFAP is a diagnostic marker for glioblastoma multiforme
C. S. Jung et al.
BRAIN (2007)
Inverse correlation between serum PGE2 and T classification in head and neck cancer
Markus Hambek et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2007)
Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia
Abderrahmane Kaidi et al.
CANCER RESEARCH (2006)
Role of β-arrestin 1 in the metastatic progression of colorectal cancer
FG Buchanan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cyclooxygenase-2: A potential target in breast cancer
DZ Wang et al.
SEMINARS IN ONCOLOGY (2004)
Inhibitory effect of a prostaglandin E receptor subtype EP1 selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice
K Watanabe et al.
CANCER LETTERS (2000)
Share Paper
